These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3886558

  • 1. Hyperoxaluria and hyperoxalemia: one more concern for the nephrologist.
    Mitwalli A, Oreopoulos DG.
    Int J Artif Organs; 1985 Mar; 8(2):71-4. PubMed ID: 3886558
    [No Abstract] [Full Text] [Related]

  • 2. Primary hyperoxaluria.
    O'Regan PF, Joekes AM.
    J R Soc Med; 1980 Aug; 73(8):541-4. PubMed ID: 7014893
    [No Abstract] [Full Text] [Related]

  • 3. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF, Sadovnic MJ, Cottington EM.
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [Abstract] [Full Text] [Related]

  • 4. Primary hyperoxaluria, treated with haemodialysis and kidney transplantation.
    Jacobsen E, Mosbaek N.
    Dan Med Bull; 1974 Apr; 21(2):72-6. PubMed ID: 4598252
    [No Abstract] [Full Text] [Related]

  • 5. [Hyperoxalemia and secondary oxalosis of chronic renal insufficiency].
    Schillinger F, Montagnac R, Milcent T.
    Nephrologie; 1990 Apr; 11(4):211-5. PubMed ID: 2074920
    [No Abstract] [Full Text] [Related]

  • 6. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
    Pru C, Eaton J, Kjellstrand C.
    Nephron; 1985 Apr; 39(2):112-6. PubMed ID: 3974772
    [Abstract] [Full Text] [Related]

  • 7. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure.
    Mydlík M, Derzsiová K.
    Kidney Int Suppl; 2001 Feb; 78():S304-7. PubMed ID: 11169031
    [Abstract] [Full Text] [Related]

  • 8. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Haubenstock A.
    Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
    [No Abstract] [Full Text] [Related]

  • 9. Renal homotransplantation in a patient with primary familial oxalosis.
    Deodhar SD, Tung KS, Zühlke V, Nakamoto S.
    Arch Pathol; 1969 Jan; 87(1):118-24. PubMed ID: 4881324
    [No Abstract] [Full Text] [Related]

  • 10. Oxalic Acid as a uremic toxin.
    Mydlík M, Derzsiová K.
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [Abstract] [Full Text] [Related]

  • 11. [Oxalate metabolism and thiamine-pyridoxine intake of the rat].
    Hauschildt S, Rudolph R, Feldheim W.
    Int J Vitam Nutr Res; 1972 Jan; 42(3):457-67. PubMed ID: 5086650
    [No Abstract] [Full Text] [Related]

  • 12. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
    Mydlík M, Derzsiová K, Svác J, Dlhopolcek P, Zemberová E.
    Artif Organs; 1998 Sep; 22(9):784-8. PubMed ID: 9754466
    [Abstract] [Full Text] [Related]

  • 13. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW, Veall N, Purkiss P.
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [Abstract] [Full Text] [Related]

  • 14. [Vitamin C and continuous ambulatory peritoneal dialysis].
    Mydlík M, Derzsiová K, Havris S, Mizla P.
    Vnitr Lek; 1983 Mar; 29(3):249-53. PubMed ID: 6858010
    [No Abstract] [Full Text] [Related]

  • 15. Long-term survival of a renal allograft in a patient with primary hyperoxaluria (type I).
    Rosier JG, Baadenhuijsen H, Koene RA.
    Neth J Med; 1981 Mar; 24(5):179-84. PubMed ID: 7029316
    [No Abstract] [Full Text] [Related]

  • 16. Major factors modulating the serum oxalic acid level in hemodialysis patients.
    Ogawa Y, Machida N, Jahana M, Gakiya M, Chinen Y, Oda M, Morozumi M, Sugaya K.
    Front Biosci; 2004 Sep 01; 9():2901-8. PubMed ID: 15353324
    [Abstract] [Full Text] [Related]

  • 17. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Sep 01; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

  • 18. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A, Fujii M, Shirai D, Mikami H, Okada A, Imai E, Ando A, Orita Y, Kamada T.
    Clin Nephrol; 1986 Apr 01; 25(4):181-5. PubMed ID: 3698351
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin C supplementation on renal oxalate deposits in five-sixths nephrectomized rats.
    Ono K, Ono H, Ono T, Kikawa K, Oh Y.
    Nephron; 1989 Apr 01; 51(4):536-9. PubMed ID: 2739830
    [Abstract] [Full Text] [Related]

  • 20. Role of pyridoxine in oxalate metabolism.
    Nath R, Thind SK, Murthy MS, Farooqui S, Gupta R, Koul HK.
    Ann N Y Acad Sci; 1990 Apr 01; 585():274-84. PubMed ID: 2192612
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.